Trial Profile
A prospective, comparison trial of Abobotulinum Toxin a (Dysport) & Onabotulinum Toxin a (Botox) in patients with spinal cord injury (SCI).
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder; Spinal cord injuries
- Focus Therapeutic Use
- 16 Dec 2015 New trial record
- 24 Oct 2014 Preliminary results presented at the 44th Annual Meeting of the International Continence Society